Yıl: 2022 Cilt: 29 Sayı: 8 Sayfa Aralığı: 777 - 783 Metin Dili: İngilizce İndeks Tarihi: 30-09-2022

Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction

Öz:
Aim: Heart failure (HF), a progressive disease, is accompanied by chronic inflammation and changes in osmolality. The neutrophil-to-lymphocyte ratio (NLR) demonstrates a sys- temic inflammatory response in most diseases; however, the relationship between plasma osmolality and the systemic inflammatory response in HF patients is not yet clear. There- fore, we aimed to investigate the possible associations of NLR with plasma osmolality levels in patients with HF. Materials and Methods: The present study included 189 consecutive patients with chronic HF with an ejection fraction (EF) of <40%. They were classified into four groups based on admission plasma osmolality quartiles: hypo-osmolar (first quartile), normo- hypo-osmolar (second quartile), normo-hyperosmolar (third quartile), and hyperosmolar (fourth quartile). We evaluated the relationship between NLR, plasma osmolality, type-B natriuretic peptide (BNP), and the New York Heart Association (NYHA) functional class. Results: The hyperosmolar group had an increased NLR (p = 0.007). The presence of NYHA class 3–4 functional capacity, high-sensitivity C-reactive protein, and high osmo- lality were independent predictors of increased NLR. In correlation analysis, osmolality was significantly positively correlated with NLR (r = 0.201, p = 0.011). Conclusion: Higher NLR values may be associated with increased plasma osmolality, which may indicate an increased inflammatory status in the HF phenomenon.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart fail- ure syndromes: current state and framework for future research. Circulation. 2005;112:3958-68.
  • 2. Earley LE, Sanders CA. The effect of changing serum osmolality on the release of antidiuretic hormone in certain patients with decompensated cirrhosis of the liver and low serum osmolality. J Clin Invest. 1959;38:545-50.
  • 3. Kaya H, Yucel O, Ege MR, et al. Plasma osmolality predicts mortality in patients with heart failure with reduced ejection fraction. Kardiol Pol. 2017;75:316-22.
  • 4. Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50:952–7.
  • 5. Zairis MN, Patsourakos NG, Tsiaousis GZ, et al. Plasma asym- metric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Heart. 2012;98:860-4.
  • 6. Cleland JG, Carubelli V, Castiello T, et al. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev. 2012;17:133-49.
  • 7. Ji Z, Liu G, Guo J, et al. The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients. Front Cardiovasc Med. 2021;8:706852.
  • 8. Curran FM, Bhalraam U, Mohan M, et al. Neutrophil-to- lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection frac- tion. ESC Heart Fail. 2021;8(4):3168-79.
  • 9. Delcea C, Buzea CA, Dan GA. The neutrophil to lymphocyte ratio in heart failure: a comprehensive review. Rom J Intern Med. 2019;57(4):296-314.
  • 10. Zengin A, Karaca M, Arugaslan E, et al. Performance of neu- trophil to lymphocyte ratio for the prediction of long-term mor- bidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syn- drome. J Cardiovasc Thorac Res. 2021;13(2):125-30.
  • 11. Yu C, Chen M, Chen Z, Lu G. Predictive and prognostic value of admission neutrophil-to-lymphocyte ratio in patients with CHD. Herz. 2016;41:605-13.
  • 12. Zafrir B, Hussein S, Jaffe R, et al. Lymphopenia and mortality among patients undergoing coronary angiography: Long-term follow-up study. Cardiol J. 2022;29(4):637-46.
  • 13. Jiang J, Zeng H, Zhuo Y, et al. Association of Neutrophil to Lymphocyte Ratio With Plaque Rupture in Acute Coronary Syndrome Patients With Only Intermediate Coronary Artery Lesions Assessed by Optical Coherence Tomography. Front Car- diovasc Med. 2022;9:770760.
  • 14. Ip WKE, Medzhitov R. Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation. Nat Commun. 2015;6:6931.
  • 15. Santos-Junior NN, Costa LHA, Catalão CHR, et al. Impairment of osmotic challenge-induced neurohypophyseal hormones secre- tion in sepsis survivor rats. Pituitary. 2017;20(5):515-21.
  • 16. Igarashi T, Fujimoto C, Suzuki H, et al. Short-time exposure of hyperosmolarity triggers interleukin-6 expression in corneal epithelial cells. Cornea. 2014;33:1342–7.
  • 17. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthe- sis in vitro. PNAS. 1995; 92:12230–4.
  • 18. Németh ZH, Deitch EA, Szabó C, Haskó G. Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin- 8 production in human intestinal epithelial cells. Am J Pathol. 2002;161:987–96.
  • 19. Sailer CO, Wiedemann SJ, Strauss K, et al. Markers of systemic inflammation in response to osmotic stimulus in healthy volun- teers. Endocr Connect. 2019;8(9):1282-7.
  • 20. Gogos CA, Giali S, Paliogianni F, et al. Interleukin-6 and C- reactive protein as early markers of sepsis in patients with dia- betic ketoacidosis or hyperosmosis. Diabetologia. 2001;44:1011– 4.
  • 21. Catapano AL, Graham I, De Backer G, et al. ESC/EAS guide- lines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999-3058.
  • 22. Russell SD, Saval MA, Robbins JL, et al. New York Heart Asso- ciation functional class predicts exercise parameters in the cur- rent era. Am Heart J. 2009;158:S24-30.
  • 23. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Soci- ety of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiogra- phy, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-63.
  • 24. Worthley LI, Guerin M, and Pain RW. For calculating os- molality, the simplest formula is the best. Anesth. Intensive care.1987;15:199-202.
  • 25. Rasouli M, Kalantari KR. Comparison of methods for calcu- lating serum osmolality: Multivariate linear regression analysis. Clin Chem Lab Med. 2005;43:635.
  • 26. Fazekas AS, Funk G-C, Klobassa DS, et al. Evaluation of 36 formulas for calculating plasma osmolality. Intensive Care Med. 2013;39:302-8.
  • 27. Wang X, Fan X, Ji S, et al. Prognostic value of neutrophil to lymphocyte ratio in heart failure patients. Clin Chim Acta. 2018;485:44-9.
  • 28. Prashar Y, Bais S, Gill NS. Emerging role of various signaling pathways in the pathogenesis and therapeutics of atherosclerosis. Vasc Med Rev. 2017;10:1-12.
  • 29. Araújo JP, Lourenço P, Azevedo A, et al. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail. 2009;15:256-66.
  • 30. Summers C, Rankin SM, Condliffe AM, et al. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31:318-24.
  • 31. Sato Y, Fujiwara H, Takatsu Y. Biochemical markers in heart failure. J Cardiol. 2012;59: 1-7.
  • 32. Cho JH, Cho HJ, Lee HY, et al. Neutrophil-Lymphocyte Ratio in Patients with Acute Heart Failure Predicts In-Hospital and Long-Term Mortality. J Clin Med. 2020;9(2).
  • 33. Majmundar M, Kansara T, Park H, et al. Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization. Int J Cardiol Heart Vasc. 2022;39:100981.
  • 34. Willermain F, Scifo L, Weber C, et al. Potential Interplay be- tween Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy. Int J Mol Sci. 2018;19(4).
  • 35. Yoshimoto S, Morita H, Matsuda M, et al. NFAT5 promotes oral squamous cell carcinoma progression in a hyperosmotic environ- ment. Lab Invest. 2021;101(1):38-50.
  • 36. Sato Y, Nakano K, Wang X, et al. Pre-Treatment Neutrophil- to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pa- zopanib Treatment for Soft-Tissue Sarcoma. Cancers (Basel). 2021;13(24).
  • 37. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guide- lines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treat- ment of acute and chronic heart failure of the European Soci- ety of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4-131.
APA BAYKIZ D, Akyüz A, Ozkaramanli Gur D, alpsoy s (2022). Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. , 777 - 783.
Chicago BAYKIZ DERYA,Akyüz Aydın,Ozkaramanli Gur Demet,alpsoy seref Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. (2022): 777 - 783.
MLA BAYKIZ DERYA,Akyüz Aydın,Ozkaramanli Gur Demet,alpsoy seref Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. , 2022, ss.777 - 783.
AMA BAYKIZ D,Akyüz A,Ozkaramanli Gur D,alpsoy s Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. . 2022; 777 - 783.
Vancouver BAYKIZ D,Akyüz A,Ozkaramanli Gur D,alpsoy s Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. . 2022; 777 - 783.
IEEE BAYKIZ D,Akyüz A,Ozkaramanli Gur D,alpsoy s "Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction." , ss.777 - 783, 2022.
ISNAD BAYKIZ, DERYA vd. "Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction". (2022), 777-783.
APA BAYKIZ D, Akyüz A, Ozkaramanli Gur D, alpsoy s (2022). Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. Annals of Medical Research, 29(8), 777 - 783.
Chicago BAYKIZ DERYA,Akyüz Aydın,Ozkaramanli Gur Demet,alpsoy seref Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. Annals of Medical Research 29, no.8 (2022): 777 - 783.
MLA BAYKIZ DERYA,Akyüz Aydın,Ozkaramanli Gur Demet,alpsoy seref Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. Annals of Medical Research, vol.29, no.8, 2022, ss.777 - 783.
AMA BAYKIZ D,Akyüz A,Ozkaramanli Gur D,alpsoy s Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. Annals of Medical Research. 2022; 29(8): 777 - 783.
Vancouver BAYKIZ D,Akyüz A,Ozkaramanli Gur D,alpsoy s Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. Annals of Medical Research. 2022; 29(8): 777 - 783.
IEEE BAYKIZ D,Akyüz A,Ozkaramanli Gur D,alpsoy s "Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction." Annals of Medical Research, 29, ss.777 - 783, 2022.
ISNAD BAYKIZ, DERYA vd. "Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction". Annals of Medical Research 29/8 (2022), 777-783.